France Neurological Biomarkers Market, Forecasts to 2035
The France Neurological Biomarkers Market is anticipated to reach USD 1457.2 million by 2035, growing at a CAGR of 13.19% from 2025 to 2035. Rising neurological disorders, advanced diagnostic technologies, and growing demand for early disease detection drive growth. The France neurological biomarkers market involves the study and application of specific biological markers used to diagnose and monitor neurological disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and stroke.